Transcriptomics

Dataset Information

0

IL-17RA blockade by brodalumab hidradenitis suppurativa


ABSTRACT: The goal of this study is to characterize the molecular response of HS patients to brodalumab therapy in skin and serum, and to identify biomarkers of treatment response. Ten participants that received 210 mg/1.5mL brodalumab subcutaneously at week 0, 1, 2, 4 and every 2 weeks after were included in this molecular profiling study (NCT03960268). RNA-sequencing of nonlesional, perilesional and lesional HS skin biopsies was assessed.

ORGANISM(S): Homo sapiens

PROVIDER: GSE189266 | GEO | 2022/04/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-12-05 | GSE245451 | GEO
2016-01-11 | E-GEOD-72702 | biostudies-arrayexpress
2016-01-11 | GSE72702 | GEO
2019-09-10 | GSE137141 | GEO
2020-02-06 | GSE144801 | GEO
2024-12-13 | GSE158955 | GEO
| EGAS00001005544 | EGA
2023-10-01 | GSE212721 | GEO
2020-11-17 | GSE148027 | GEO
2024-08-22 | PXD050245 | Pride